CHEBI:176897 - GSK-5498A

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name GSK-5498A
ChEBI ID CHEBI:176897
Definition A member of the class of pyrazoles that is 1H-pyrazole substituted by 2-fluoro-6-(trifluoromethyl)benzyl and (2,6-difluorobenzoyl)amino groups at positions 1 and 3, respectively. It is a inhibitor of Ca2+ release-activated Ca2+ (CRAC) channel and inhibits the release of mast cell mediators and T-cell cytokines in human and rat preparations.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Ceri
Supplier Information
Download Molfile XML SDF
Formula C18H11F6N3O
Net Charge 0
Average Mass 399.296
Monoisotopic Mass 399.08063
InChI InChI=1S/C18H11F6N3O/c19-12-4-1-3-11(18(22,23)24)10(12)9-27-8-7-15(26-27)25-17(28)16-13(20)5-2-6-14(16)21/h1-8H,9H2,(H,25,26,28)
InChIKey AUBGZAJDHUHMAE-UHFFFAOYSA-N
SMILES FC1=CC=CC(F)=C1C(=O)NC1=NN(CC2=C(F)C=CC=C2C(F)(F)F)C=C1
Roles Classification
Biological Role(s): calcium channel blocker
One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing GSK-5498A (CHEBI:176897) has role calcium channel blocker (CHEBI:38215)
GSK-5498A (CHEBI:176897) is a (trifluoromethyl)benzenes (CHEBI:83565)
GSK-5498A (CHEBI:176897) is a difluorobenzene (CHEBI:38582)
GSK-5498A (CHEBI:176897) is a pyrazoles (CHEBI:26410)
GSK-5498A (CHEBI:176897) is a secondary carboxamide (CHEBI:140325)
IUPAC Name
2,6-difluoro-N-{1-[2-fluoro-6-(trifluoromethyl)benzyl]-1H-pyrazol-3-yl}benzamide
Synonyms Sources
2,6-difluoro-N-(1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1H-pyrazol-3-yl)benzamide IUPAC
GSK 5498A ChEBI
GSK5498A ChEBI
Registry Number Type Source
1253186-49-0 CAS Registry Number ChEBI
Citations Waiting for Citations Types Sources
23454522 PubMed citation Europe PMC
27396568 PubMed citation Europe PMC
Last Modified
23 July 2021